Halcion (Triazolam)

Halcion (triazolam) is indicated for the short‑term management of insomnia when rapid sleep onset is required.

• Short‑term treatment of difficulty falling asleep.
• Use in adults who need a rapid onset of sleep for up to a few nights.
• May be prescribed when non‑pharmacologic sleep hygiene measures are insufficient.
• Typically limited to a brief course to reduce risk of dependence.
• Occasionally used off‑label for pre‑procedural anxiolysis under specialist supervision.

Side effects reported with Halcion vary in frequency and severity, ranging from mild, transient symptoms to rare but serious reactions that may require medical intervention.

Common

• Drowsiness or fatigue that may affect daytime alertness.
• Dizziness or a light‑headed sensation, especially after standing quickly.
• Impaired coordination or balance, increasing fall risk.
• Short‑term memory disturbances, such as difficulty recalling recent events.
• Headache or mild gastrointestinal discomfort.

Serious

• Severe allergic reactions, including rash, swelling of the face or throat, or difficulty breathing, requiring immediate medical attention.
• Paradoxical reactions such as increased agitation, aggression, anxiety, or vivid hallucinations, which are uncommon but serious.
• Respiratory depression or profound sedation, particularly when Halcion is taken with other central nervous system depressants like alcohol or opioids.

Precautions should be considered before initiating Halcion therapy to minimize risks and ensure safe use.

• Assess for a history of substance abuse, dependence, or withdrawal from benzodiazepines.
• Use the lowest effective dose for the shortest duration, typically not exceeding a few nights.
• Caution in elderly patients due to increased sensitivity and fall risk.
• Avoid use during pregnancy or breastfeeding unless clearly indicated, as safety data are limited.
• Monitor for signs of depression, suicidal thoughts, or behavioral changes.
• Do not combine with alcohol, opioids, or other central nervous system depressants.

Halcion can interact with other medications, affecting its sedative effect or increasing the risk of adverse reactions.

Avoid

• Alcohol and other CNS depressants (e.g., opioids, barbiturates, antihistamines) due to additive sedation and respiratory depression.
• Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, erythromycin) which can raise triazolam plasma levels.

Use with caution

• Other benzodiazepines or sleep aids, as combined use may enhance sedation.
• Antidepressants such as fluoxetine or sertraline, which may affect metabolism.
• Anticonvulsants like carbamazepine that can lower triazolam concentrations.
• Herbal supplements containing St. John’s wort, a CYP3A4 inducer, potentially reducing efficacy.